Louisiana State Employees Retirement System Sells 300 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Louisiana State Employees Retirement System cut its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 5.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,300 shares of the company’s stock after selling 300 shares during the quarter. Louisiana State Employees Retirement System’s holdings in USANA Health Sciences were worth $201,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Pzena Investment Management LLC raised its position in shares of USANA Health Sciences by 24.4% in the second quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock valued at $44,183,000 after purchasing an additional 191,289 shares during the period. Dimensional Fund Advisors LP increased its position in USANA Health Sciences by 0.6% during the second quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock worth $30,907,000 after acquiring an additional 3,889 shares during the period. Pacer Advisors Inc. increased its position in USANA Health Sciences by 14.3% during the second quarter. Pacer Advisors Inc. now owns 467,352 shares of the company’s stock worth $21,143,000 after acquiring an additional 58,597 shares during the period. American Century Companies Inc. increased its position in USANA Health Sciences by 12.3% during the second quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock worth $7,229,000 after acquiring an additional 17,460 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in USANA Health Sciences by 13.5% during the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after acquiring an additional 14,756 shares during the period. 54.25% of the stock is owned by institutional investors.

USANA Health Sciences Stock Up 3.5 %

USNA stock opened at $40.33 on Thursday. USANA Health Sciences, Inc. has a 12 month low of $34.15 and a 12 month high of $54.81. The firm has a market cap of $768.37 million, a P/E ratio of 14.25, a P/E/G ratio of 1.29 and a beta of 0.89. The company’s 50-day moving average price is $37.53 and its two-hundred day moving average price is $42.07.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The firm had revenue of $200.22 million for the quarter, compared to analyst estimates of $208.45 million. During the same period last year, the firm earned $0.59 EPS. Equities analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Buying and Selling at USANA Health Sciences

In other news, insider Paul A. Jones sold 6,266 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total value of $240,489.08. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, insider Paul A. Jones sold 6,266 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total value of $240,489.08. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Gilbert A. Fuller sold 675 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on USNA shares. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. DA Davidson lowered their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 23rd.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.